SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 19th, 2024 • Marker Therapeutics, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 19, 2024, is by and among Marker Therapeutics, Inc., a Delaware corporation with offices located at 2450 Holcombe Blvd, Suite BCM-A, MS: BCM251, Houston, Texas 77054 (the “Company”), and each of the investors signatory hereto (individually, a “Buyer” and collectively, the “Buyers”).
